AGP Executive Report
Last update: 6 hours agoDisease Preparedness: Singapore has launched an Asia-Pacific initiative to spot emerging infectious disease threats earlier. Cancer Prevention: From Dec 1, eligible people at hereditary risk of breast and ovarian cancer can access genetic testing at three public healthcare clusters, with means-tested subsidies of up to 70%. Mental Health: NUH and NUS report encouraging early results from personalised brain stimulation for severe OCD, and are extending the approach to depression and anxiety. Haze and Health: Hospital and polyclinic visits rose by at least 20% after haze began in September, while experts warn longer-term health effects need more attention. New Treatments: Singapore has approved ruxolitinib cream for vitiligo, offering a new treatment option. Healthy Ageing: Fullerton Health has opened a Singapore centre focused on prevention, with regular follow-ups rather than annual check-ups. Nicotine Controls: Snus and nicotine pouches are now banned in Singapore, including for transit passengers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
